Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Syneos Health, a combo CRO/CCO, said it plans to make a secondary stock offering of 6 million shares priced to the public at $50.15 per share.
Premier Research, a global CRO, acquired Regulatory Professionals and will merge the firm into a new division.
Insmed aims to bring a first-in-market therapy to patients in the U.S. suffering from NTM lung disease caused by MAC, a chronic and debilitating condition.
Novartis will partner with Albumedix to explore using the company’s technology as a possible drug delivery platform for several therapies.
Clinical research helper WIRB-Copernicus Group has acquired KMR Group and Metrics Consortium to bolster its market insights and intelligence division.
Healx has reeled in $10 million in series A funding it plans to use to hire more researchers and enhance its AI platform.
Pharma giant Novartis has signed Shyft, a Medidata Solutions subsidiary, to help strengthen its digital solutions.
Isogenica inked a licensing deal with Aro Biotherapeutics to use in vitro polypeptide display systems to develop Aro’s scaffold molecule technology.
Synexus is partnering with the University of Exeter to launch a registry-based study in the U.S. to better understand how healthy brains age.
Novotech has inked a partnership deal with the Asian Eye Institute for clinical research with the ophthalmology firm.
BMJ authors are calling for more coordination between regulatory agencies in the Americas to improve health data transparency in clinical trials.
